Comparing the experimental or vaccinated broilers over the controls, the studies indicated:
Research shows that while Salmogenics can reduce the levels of fecal Salmonella when injected in-ovo (in the egg) in broilers, it also suggests that performance may have improved to levels of statistical value in these chickens.
If you assume that all of the 40 billion broiler chickens in the world are injected with Salmogenics, then the following benefits can be calculated.
Poultry production is projected to rise the most among the meats over the next decade, as poultry is the most efficient feed-to-meat converter. Demand for poultry also remains strong because of its lower cost relative to beef and pork. Improved broiler performance indicates an average of a .126 pounds weight gain, with each bird weighing an average of 5.73 pounds at the end of 49 days.
Citing USDA composite prices based on whole carcass weight, the National Chicken Council reported earlier that, price per pound, from 2002 to 2012:
Our study indicates mortality rate dropping from 3.281% to 1.406% with the use of Salmogenics, a 57% improvement.
“We are excited about the preliminary results of the trial studies. When extrapolating the weight gain with Salmogenics-vaccinated broilers, the reduced mortality of the bird, and the ever-increasing cost of chicken to the consumer, the potential of the Salmogenics vaccine on the poultry industry would have far-reaching impact,” Dr. Ghazvini concluded.
The Salmogenics vaccine is in its last stages of testing and trials before the final United States Department of Agriculture/Food Safety and Inspection Service (“USDA”) approval for its commercial application.
SOURCE Global Green, Inc.